Russell Patrick Sawyer , MD

MD: St. George's University Medical School Grenada, West Indies, 2013 (Medicine)

Bachelor of Science: University of California Davis Davis, CA, 2008 (Psychology, Minor-Neuroscience)

Residency: University of Cincinnati Medical Center Cincinnati, Ohio, 2016 (Neurology)

Fellowship: University of Cincinnati Medical Center Cincinnati, Ohio, 2017 (Behavioral Neurology)

American Board of Psychiatry and Neurology (Neurology) (Certification Date: 09-11-2017 )

United Council for Neurologic Subspecialties (Certification Date: 11-30-2018 )

Cognitive Aging

Cognitive Disorders

Internal Medicine

Alzheimer's Disease

Amnesia

Aphasia

Chronic Traumatic Encephalopathy

Cognition Disorders

Dementia

Dysarthria

Early Anset Dementia

Epilepsy-Related Cognitive Dysfunction

Frontotemporal Lobar Degeneration

Lewy Body Dementia

Lewy Body Disease

Mad Cow Disease (Creutzfeldt-Jakob disease)

Memory Disorders

Metabolic Brain Disease

Mild Cognitive Impairment

Multi-Infarct Dementia

Multiple System Atrophy (MSA)

Neuralgias

Neuropathic Facial Pain

Normal Pressure Hydrocephalus

Orthostatic Hypotension (Postural Hypotension)

Paraphasic Error

Paroxysmal Hemicrania

Pick's Disease (Frontotemporal dementia)

Posterior Cortical Atrophy

Postherpetic Neuralgia

Post-Traumatic Headache

Prion Disease

Pseudobulbar Palsy

Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)

Rare Cognitive Disorders

Stroke-Related Cognitive Dysfunction

Tauopathies

TDP-43 Proteinopathies

Vascular Cognitive Impairment

Vascular Dementia

Behavioral Neurology & Neuropsychiatry

Neurology

Dementia, Memory Disorder, Cognitive Behavioral

Grant: #R01AG072592 Investigators:Hyacinth, Hyacinth; Niu, Liang; Sawyer, Russell 09-15-2021 -05-31-2026 National Institute on Aging Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimer's disease and its related dementias (transfer application) Role:Collaborator 1505134.00 Awarded Level:Federal

Grant: #AL002-2 (Invoke) 01-01-2023 -12-31-2025 PPD A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants with Early Alzheimer's Disease Role:PI 0.00 Hold Level:Industry

Grant: #AL002-2 (Invoke) 01-01-2023 -12-31-2025 PPD A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants with Early Alzheimer's Disease Role:PI 0.00 Hold Level:Industry

Grant: #Columbia; tba/tba Investigators:Sawyer, Russell 07-01-2023 -04-30-2026 National Institute on Aging Metformin in Alzheimer's dementia Prevention (MAP) Role:PI 244016.80 Hold Level:Federal

01-23-2024 -01-25-2027 PPD A Continuation Study of Latozinemab in Participants with Neurodegenerative Disease Role:PI 302631.81 Hold Level:Industry

01-23-2024 -01-25-2027 PPD A Continuation Study of Latozinemab in Participants with Neurodegenerative Disease Role:PI 302631.81 Hold Level:Industry

02-12-2024 -02-08-2027 IQVIA Clinical Trial Payments A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer's Disease o Role:PI 372444.01 Active Level:Industry

02-12-2024 -02-08-2027 IQVIA Clinical Trial Payments A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer's Disease o Role:PI 372444.01 Active Level:Industry

Grant: #1R01NS140155-01 Investigators:Demel, Stacie; Sawyer, Russell; Walsh, Kyle; Woo, Daniel -08-31-2028 National Institute of Neurological Disorders and Stroke Metabolomics of ICH recovery (METABOL-ICH) Role:Collaborator 0.00 Hold Level:Federal

Investigators:Sawyer, Russell 05-30-2024 -05-30-2028 PPD AL002: A Multicenter, Long Term Extension Study to Evaluate the safety, tolerability and efficacy of AL002 in Participants with Alzheimer's disease. Role:PI 111221.67 Hold Level:Industry

Grant: #tba, 2RF1NS041588-22A1 Investigators:Flaherty, Matthew; Hyacinth, Hyacinth I.; Kissela, Brett; Robinson, David; Sawyer, Russell; Stanton, Robert 09-17-2024 -08-31-2026 National Institute of Neurological Disorders and Stroke Understanding Cohort Effects on Stroke, VCID, and Cognition After Major Epidemiologic Transitions Role:Collaborator 582232.00 Hold Level:Federal

Peer Reviewed Publications

Sawyer, Russell P; Rodriguez-Porcel, Federico; Hagen, Matthew; Shatz, Rhonna; Espay, Alberto J (2017. ) Diagnosing the frontal variant of Alzheimer's disease: a clinician's yellow brick road.Journal of clinical movement disorders, , 4 ,2 More Information

Sawyer, Russell P; Sekar, Padmini; Osborne, Jennifer; Kittner, Steven J; Moomaw, Charles J; Flaherty, Matthew L; Langefeld, Carl D; Anderson, Christopher D; Rosand, Jonathan; Woo, Daniel (2018. ) Racial/ethnic variation of APOE alleles for lobar intracerebral hemorrhage.Neurology, , More Information

Merola, Aristide; Sawyer, Russell P; Artusi, Carlo Alberto; Suri, Ritika; Berndt, Zoe; Lopez-Castellanos, Jose' Ricardo; Vaughan, Jennifer; Vizcarra, Joaquin A; Romagnolo, Alberto; Espay, Alberto J (2018. ) Orthostatic hypotension in Parkinson disease: Impact on health care utilization.Parkinsonism & related disorders, , 47 ,45-49 More Information

Academic - Stetson Building
Suite 2300
Cincinnati  Ohio, 45219
Phone: 513-558-2968
russell.sawyer@uc.edu